Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Glass A"'
Autor:
Bassam Estfan, Marc A. Shapiro, Robert Pelley, R. Matthew Walsh, Katherine Glass, Alok A. Khorana, Jane Wey, Shiva Shrotriya, Gareth Morris-Stiff, Michael J. McNamara, Sricharan Chalikonda, Davendra Sohal
Publikováno v:
Cancer. 121:1779-1784
BACKGROUND: Survival after surgical resection for pancreatic cancer remains poor. A subgroup of patients die early (
Autor:
Michelle R. Glass, Michael A. Davies, Alexander J. Lazar, Sapna Pradyuman Patel, Carol Vaughn, Patricia LoRusso, Kevin B. Kim, Roger B. Cohen, Ping Liu, Jeffrey R. Infante, Nicholas E. Papadopoulos
Publikováno v:
Cancer. 119:799-805
BACKGROUND: The high prevalence of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) and neuroblastoma v-ras oncogene homolog (NRAS) mutations in melanoma provides a strong rationale to test the clinical efficacy of mitogen-activated protein kina
Autor:
Timothy N. Showalter, Maria Werner-Wasik, Xinglei Shen, Adam P. Dicker, Jon Glass, Mark V. Mishra, David W. Andrews, Zvi Symon, Yaacov Richard Lawrence
Publikováno v:
Cancer. 118:4228-4234
BACKGROUND: Glioblastoma multiforme (GBM) is the most frequent primary brain tumor in adults. Temozolomide was rapidly incorporated into first-line treatment following the publication of the pivotal European Organization for Research and Treatment of
Autor:
Najat C. Daw, Fredric A. Hoffer, Jianrong Wu, Wilburn E. Reddick, Sue C. Kaste, Junyu Guo, Qing Ji, Jesse J. Jenkins, John O. Glass, Ximena C. Ortega Flores, Catherine A. Billups, Milena Villarroel, Juan Quintana
Publikováno v:
Cancer. 118:3776-3785
BACKGROUND: The objective of this study was to prospectively evaluate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as an early imaging indicator of tumor histologic response to preoperative chemotherapy and as a possible prognostic
Autor:
Evan Wuthrick, Rita Axelrod, Terry Hyslop, Maria Werner-Wasik, David W. Andrews, Kevin Camphausen, Walter J. Curran, Mitchell Machtay, Jon Glass, Mitchell Kamrava, Adam P. Dicker
Publikováno v:
Cancer. 117:5548-5559
BACKGROUND: In this phase 1 trial, the authors evaluated sunitinib combined with radiation therapy (RT) for the treatment of primary or metastatic central nervous system (CNS) malignancies. METHODS: Eligible patients had CNS malignancies that require
Autor:
Raja B. Khan, Susan Helton, Shengjie Wu, John O. Glass, Wilburn E. Reddick, Scott C. Howard, Raymond K. Mulhern, Zuyao Y. Shan, Robbin Christensen, Melanie J. Bonner, Xiaoping Xiong, Ching-Hon Pui
Publikováno v:
Cancer. 106:941-949
BACKGROUND The primary objective of this study was to test the hypothesis that survivors of childhood acute lymphoblastic leukemia (ALL) have deficits in neurocognitive performance, and smaller white-matter volumes are associated with these deficits.
Autor:
Michael Kneba, Michael Pfreundschuh, Bernd Metzner, Marcel Reiser, Lorenz Trümper, Markus Loeffler, Bertram Glass, Marita Kloess, Nobert Schmitz M.D., Bernd Dörken, Wolfgang E. Berdel
Publikováno v:
Cancer. 106:136-145
BACKGROUND Patients with aggressive lymphoma and high-risk features at the time of diagnosis are reported to have a poor prognosis with standard therapy. Attempts to improve the results achieved with the combination of cyclophosphamide, doxorubicin,
Autor:
Davendra P S, Sohal, Shiva, Shrotriya, Kate Tullio, Glass, Robert J, Pelley, Michael J, McNamara, Bassam, Estfan, Marc, Shapiro, Jane, Wey, Sricharan, Chalikonda, Gareth, Morris-Stiff, R Matthew, Walsh, Alok A, Khorana
Publikováno v:
Cancer. 121(11)
Survival after surgical resection for pancreatic cancer remains poor. A subgroup of patients die early (6 months), and understanding factors associated with early mortality may help to identify high-risk patients. The Khorana score has been shown to
Autor:
B S Franklin Demuth, David R. Scott, Brenda B. Rush, Mark Schiffman, Philip E. Castle, Attila T. Lorincz, Mark E. Sherman, Andrew G. Glass, Sholom Wacholder
Publikováno v:
Cancer. 95:2145-2151
BACKGROUND The addition of human papillomavirus (HPV) DNA testing to cytologic screening for cervical carcinoma is now being considered. The majority of women in screening cohorts who test positive for oncogenic types of HPV DNA have concurrent negat
Publikováno v:
Cancer. 94:862-871
BACKGROUND Most studies of treatment outcomes in men with localized prostate carcinoma have emphasized sexual, urinary, and bowel symptoms with the assumption that they have an impact on quality of life. However, very few studies have directly examin